Raptor Pharma (RPTP) Tops Q3 EPS by 14c

Raptor Pharma (NASDAQ: RPTP) reported Q3 EPS of ($0.04), $0.14 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $23.8 million versus the consensus estimate of $18.9 million.

For earnings history and earnings-related data on Raptor Pharma (RPTP) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Yeti Holdings Inc. (YETI) PT Raised to $45 at Stifel on Beat and Raise Q2 Results
• Piper Sandler Reiterates Overweight Rating on KKR (KKR), 'highest conviction name'